Welcome to our dedicated page for United States Antimony SEC filings (Ticker: UAMY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
United States Antimony Corporation filings document the public-company record for an antimony, zeolite and critical-minerals producer and processor. Recent 8-K reports cover operating and financial results, conference-call materials, officer and finance-leadership changes, and operational updates tied to the Fostung tungsten property and its Technical Report Summary.
The company’s proxy materials describe annual-meeting voting matters and shareholder governance procedures. Its Form 25 records the withdrawal of common stock from NYSE American following the completed transfer of the listing to the New York Stock Exchange, while later current reports identify UAMY common stock as listed on the NYSE and NYSE Texas. The filings also disclose the company’s common stock class, par value, reporting status, and material-event exhibits.
United States Antimony Corp director Michael A. McManus Jr. reported equity awards under the company’s Amended & Restated 2023 Equity Incentive Plan. On January 15, 2026, he acquired 6,635 shares of common stock at $0 as part of a time-based restricted stock unit grant. These shares represent one-third of a larger 19,903-share RSU award, with the remaining portions scheduled to vest in equal tranches on January 15, 2027 and January 18, 2028, subject to his continued service.
He was also granted a stock option for 12,259 shares of common stock at an exercise price of $8.29 per share, vesting in three equal installments of 4,087 shares on January 15, 2027, January 18, 2028, and January 16, 2029, again contingent on continued service. Following these transactions, McManus beneficially owned 538,600 shares of common stock directly.
United States Antimony Corp. director Joseph A. Carrabba reported new equity awards and share ownership changes. On January 15, 2026, he acquired 6,635 shares of common stock at a price of $0, representing the first one-third tranche of a 19,903-share time-based restricted stock unit award under the Amended & Restated 2023 Equity Incentive Plan. After this transaction, he beneficially owned 112,702 shares of common stock directly.
On the same date, he was also granted a stock option covering 12,259 shares of common stock at an exercise price of $8.29 per share. The option is scheduled to vest in three equal installments of 4,087 shares each on January 15, 2027, January 18, 2028 and January 16, 2029, subject to his continued service through each vesting date.
United States Antimony Corp. director Blaise A. Aguirre reported new equity awards under the company’s Amended & Restated 2023 Equity Incentive Plan. On January 15, 2026, he acquired 6,635 shares of common stock at $0 as the first vesting tranche of a 19,903-share time-based restricted stock unit award. After this vesting, he beneficially owned 496,001 common shares directly.
On the same date, he was also granted a stock option for 12,259 shares with an exercise price of $8.29 per share. This option vests in three equal installments of 4,087 shares each on January 15, 2027, January 18, 2028, and January 16, 2029, subject to his continued service. These awards align his compensation more closely with the future performance of United States Antimony Corp.
United States Antimony Corporation reported that it has closed on the acquisition of a critical minerals flotation facility located in Radersburg, Montana. The facility, which is fully operational and situated between Helena and Bozeman, was acquired on January 16, 2026 for $4.75 million in cash, representing an immediate investment outflow.
The company has also budgeted approximately $2 million in future capital expenditures to make specific improvements to the newly acquired property and equipment. Details of the transaction and planned upgrades are described further in a related press release furnished as an exhibit.
United States Antimony Corp director Jon R. Marinelli reported new equity-based awards tied to his service with the company. He was granted derivative rights over 24,509 shares of common stock through a time-based restricted stock unit award under the Amended & Restated 2023 Equity Incentive Plan. One-third, or 8,170 shares, will vest on December 4, 2026, with additional one‑third portions vesting on December 4, 2027 and December 4, 2028, if he continues in service.
Marinelli was also granted stock options covering 15,182 shares of common stock at an exercise price of $6.12 per share. These options vest in three equal installments of 5,061 shares on December 4, 2026, December 4, 2027, and December 4, 2028, contingent on his continued service through each vesting date.
United States Antimony Corporation filed a current report to let investors know it has issued a new shareholder letter. The company states that the letter, dated January 5, 2026, has been provided as Exhibit 99.1 to this report and is incorporated by reference. The information is furnished under Regulation FD, which means it is intended to share the same information with all investors at the same time rather than being treated as formally filed financial statements.
United States Antimony Corporation (UAMY) reported that its Board of Directors has appointed Jon R. Marinelli as a new director, effective November 24, 2025. With his addition, the Board increases to seven members, of which five are independent, and he will also serve as Chairman of a newly formed Finance Committee.
Marinelli brings more than 25 years of experience in capital markets, M&A, and strategic advisory work, including leadership roles at BMO Capital Markets and Deutsche Bank’s natural resources group, and has advised on over $285 billion in transactions. He will serve until the next annual shareholder meeting under the company’s standard non-employee director compensation program, and there are no related-party transactions requiring disclosure.
United States Antimony Corporation furnished an 8-K under Item 2.02 to provide the transcript of its conference call discussing financial and operational results for the third quarter and nine months ended September 30, 2025. A replay is available on the company’s website until November 26, 2025.
The transcript is attached as Exhibit 99.1 and is being furnished, not filed, which limits potential liability under the Exchange Act. The filing also includes customary forward‑looking statements cautions.
United States Antimony Corporation furnished a press release reporting its financial and operational results for the third quarter and nine months ended September 30, 2025.
The press release was provided as Exhibit 99.1 to this Form 8-K under Item 2.02 and is incorporated by reference. The information in Item 2.02, including Exhibit 99.1, is being furnished and is not deemed “filed” for purposes of Section 18 of the Exchange Act. The company also included customary forward‑looking statements language.
United States Antimony Corporation reported sharply higher sales and larger losses in its Q3 results. Revenue rose to $8,701,951 from $2,572,178 a year ago, driven by antimony products, while gross profit reached $2,013,442. The company posted a net loss of $4,780,700 as operating expenses jumped, including non‑cash share‑based compensation.
Year to date, revenue was $26,227,079. The balance sheet strengthened with cash and cash equivalents of $18,338,679 and held‑to‑maturity U.S. Treasury Strips at $20,157,393 amortized cost. Operating cash flow was $(6,220,686), offset by $42,415,350 provided by financing activities, including an at‑the‑market sale and a registered direct offering; warrant exercises added cash as well.
The company disclosed a five‑year IDIQ contract with the DLA Strategic Materials for antimony metal ingots, with a maximum value of $245 million through September 2030. An initial delivery order for 315,000 pounds is valued at approximately $10 million; no revenue has been recognized yet. Inventory increased to $8,413,161, PP&E to $28,121,338, and management booked a $469,822 gain on early termination of a Montana lease.